Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, and specialty diagnostics worldwide. The company serves pharmaceutical, biotechnology, academic, government, and environmental customers.
Thermo Fisher Scientific Inc. operates in the Healthcare sector and is a constituent of the S&P 500 index. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for TMO.
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). TMO Stock Intelligence Report. [stoxpulse.com/stocks/tmo]
Disclaimer: The information on this page about Thermo Fisher Scientific Inc. (TMO) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Thermo Fisher Scientific Inc..
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
Earnings beat by 3%
Mar 31
WEISLER sold 80.287 shares
May 20
WEISLER bought 499 shares
May 20
ICLR Earnings Reset: What the Accounting Probe Cha...
5h ago
The Bull Case For Thermo Fisher Scientific (TMO) C...
23h ago
StoxPulse AI results for TMO: Pulse Score 44.5/100. Primary sentiment trends from 15 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$176.31B
P/E Ratio
26.6
EPS
$4.43
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Jun 25
+1.6%
Sep 25
+4.4%
Dec 25
+0.9%
Mar 26
+2.8%
Beat estimates 4 of 4 quarters (100%)
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, and specialty diagnostics worldwide. The company serves pharmaceutical, biotechnology, academic, government, and environmental customers.
ICLR Earnings Reset: What the Accounting Probe Changed
The Bull Case For Thermo Fisher Scientific (TMO) Could Change Following AI-Enhanced Orbitrap Drug Discovery Launches – Learn Why
TransMedics (TMDX) Down 4.4% Since Last Earnings Report: Can It Rebound?
Jim Cramer on Danaher: “At These Prices, It’s Clearly Overvalued”
HSBC Downgrades Thermo Fisher Scientific (TMO)
QuidelOrtho's Respiratory Exposure Remains a Key Near-Term Risk
Yum! Brands upgraded, Chipotle downgraded: Wall Street's top analyst calls
HSBC Downgrades Thermo Fisher Scientific to Hold, Lowers Price Target to $540